# Dose-dEscalated MR-Guided Radiotherapy for Localized Prostate Cancer

> **NCT07674225** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 24 (actual)

## Conditions studied

- Intermediate Risk Prostate Cancer (Diagnosis)
- Prostate Cancer

## Interventions

- **RADIATION:** Prostate radical radiotherapy
- **RADIATION:** Prostate radical radiotherapy

## Key facts

- **NCT ID:** NCT07674225
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-03-22
- **Primary completion:** 2028-06-01
- **Final completion:** 2030-06-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-09-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07674225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07674225, "Dose-dEscalated MR-Guided Radiotherapy for Localized Prostate Cancer". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07674225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*